{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:01:09Z","timestamp":1787025669012,"version":"build-2736575974"},"reference-count":60,"publisher":"The Society for Free Radical Research Japan","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Clin. Biochem. Nutr."],"published-print":{"date-parts":[[2025]]},"DOI":"10.3164\/jcbn.24-86","type":"journal-article","created":{"date-parts":[[2024,8,28]],"date-time":"2024-08-28T18:13:03Z","timestamp":1724868783000},"page":"64-84","source":"Crossref","is-referenced-by-count":8,"title":["Single-cell analysis reveals islet autoantigen\u2019s immune activation in type 1 diabetes patients"],"prefix":"10.3164","volume":"76","author":[{"given":"Takuro","family":"Okamura","sequence":"first","affiliation":[{"name":"Department of Endocrinology and Metabolism, Kyoto Prefectural University of Medicine, Graduate School of Medical Science"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriyuki","family":"Kitagawa","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Kyoto Prefectural University of Medicine, Graduate School of Medical Science"},{"name":"Department of Diabetology, Kameoka Municipal Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuko","family":"Kitagawa","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Kyoto Prefectural University of Medicine, Graduate School of Medical Science"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimiko","family":"Sakai","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Kyoto Prefectural University of Medicine, Graduate School of Medical Science"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madoka","family":"Sumi","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Kyoto Prefectural University of Medicine, Graduate School of Medical Science"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Genki","family":"Kobayashi","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Kyoto Prefectural University of Medicine, Graduate School of Medical Science"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Imai","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Kyoto Prefectural University of Medicine, Graduate School of Medical Science"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takaaki","family":"Matsui","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Kyoto Prefectural University of Medicine, Graduate School of Medical Science"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahide","family":"Hamaguchi","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Kyoto Prefectural University of Medicine, Graduate School of Medical Science"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michiaki","family":"Fukui","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Kyoto Prefectural University of Medicine, Graduate School of Medical Science"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1739","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1 Boldison J, Wong FS. Immune and pancreatic \u03b2 cell interactions in type 1 diabetes. Trends Endocrinol Metab 2016; 27: 856\u2013867.","DOI":"10.1016\/j.tem.2016.08.007"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2 Diana J, Simoni Y, Furio L, et al. Crosstalk between neutrophils, B-1a cells and plasmacytoid dendritic cells initiates autoimmune diabetes. Nat Med 2013; 19: 65\u201373.","DOI":"10.1038\/nm.3042"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3 Katz JD, Benoist C, Mathis D. T helper cell subsets in insulin-dependent diabetes. Science 1995; 268: 1185\u20131188.","DOI":"10.1126\/science.7761837"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4 Emamaullee JA, Davis J, Merani S, et al. Inhibition of Th17 cells regulates autoimmune diabetes in NOD mice. Diabetes 2009; 58: 1302\u20131311.","DOI":"10.2337\/db08-1113"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5 Putnam AL, Brusko TM, Lee MR, et al. Expansion of human regulatory T-cells from patients with type 1 diabetes. Diabetes 2009; 58: 652\u2013662.","DOI":"10.2337\/db08-1168"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6 Cole DK, Bulek AM, Dolton G, et al. Hotspot autoimmune T cell receptor binding underlies pathogen and insulin peptide cross-reactivity. J Clin Invest 2016; 126: 2191\u20132204.","DOI":"10.1172\/JCI85679"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7 Michels AW, Landry LG, McDaniel KA, et al. Islet-derived CD4 T cells targeting proinsulin in human autoimmune diabetes. Diabetes 2017; 66: 722\u2013734.","DOI":"10.2337\/db16-1025"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8 Wang Y, Hao L, Gill RG, Lafferty KJ. Autoimmune diabetes in NOD mouse is L3T4 T-lymphocyte dependent. Diabetes 1987; 36: 535\u2013538.","DOI":"10.2337\/diabetes.36.4.535"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9 Shizuru JA, Taylor-Edwards C, Banks BA, Gregory AK, Fathman CG. Immunotherapy of the nonobese diabetic mouse: treatment with an antibody to T-helper lymphocytes. Science 1988; 240: 659\u2013662.","DOI":"10.1126\/science.2966437"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10 Roep BO, Peakman M. Diabetogenic T lymphocytes in human type 1 diabetes. Curr Opin Immunol 2011; 23: 746\u2013753.","DOI":"10.1016\/j.coi.2011.10.001"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11 Atkinson MA, Eisenbarth GS, Michels AW. Type 1 diabetes. The Lancet 2014; 383: 69\u201382.","DOI":"10.1016\/S0140-6736(13)60591-7"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12 Maecker HT, Lindstrom TM, Robinson WH, et al. New tools for classification and monitoring of autoimmune diseases. Nat Rev Rheumatol 2012; 8: 317\u2013328.","DOI":"10.1038\/nrrheum.2012.66"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13 Okamura T, Hamaguchi M, Tominaga H, et al. Characterization of peripheral blood TCR in patients with type 1 diabetes mellitus by BD rhapsody<sup>TM<\/sup> VDJ CDR3 assay. Cells 2022; 11: 1623.","DOI":"10.3390\/cells11101623"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14 Pugliese A. Autoreactive T cells in type 1 diabetes. J Clin Invest 2017; 127: 2881\u20132891.","DOI":"10.1172\/JCI94549"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15 Bender C, Rodriguez-Calvo T, Amirian N, Coppieters KT, von Herrath MG. The healthy exocrine pancreas contains preproinsulin-specific CD8 T cells that attack islets in type 1 diabetes. Sci Adv 2020; 6: eabc5586.","DOI":"10.1126\/sciadv.abc5586"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16 Herold KC, Hagopian W, Auger JA, et al. Anti-CD3 monoclonal antibody in new-onset type 1 diabetes mellitus. N Engl J Med 2002; 346: 1692\u20131698.","DOI":"10.1056\/NEJMoa012864"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17 Keymeulen B, Vandemeulebroucke E, Ziegler AG, et al. Insulin needs after CD3-antibody therapy in new-onset type 1 diabetes. N Engl J Med 2005; 352: 2598\u20132608.","DOI":"10.1056\/NEJMoa043980"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18 Herold KC, Bundy BN, Long SA, et al. An anti-CD3 antibody, teplizumab, in relatives at risk for type 1 diabetes. N Engl J Med 2019; 381: 603\u2013613.","DOI":"10.1056\/NEJMoa1902226"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19 Geers D, Shamier MC, Bogers S, et al. SARS-CoV-2 variants of concern partially escape humoral but not T-cell responses in COVID-19 convalescent donors and vaccinees. Sci Immunol 2021; 6: eabj1750.","DOI":"10.1126\/sciimmunol.abj1750"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20 Aiello A, Najafi Fard S, Petruccioli E, et al. Spike is the most recognized antigen in the whole-blood platform in both acute and convalescent COVID-19 patients. Int J Infect Dis 2021; 106: 338\u2013347.","DOI":"10.1016\/j.ijid.2021.04.034"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21 Kim J, Richter W, Aanstoot HJ, et al. Differential expression of GAD65 and GAD67 in human, rat, and mouse pancreatic islets. Diabetes 1993; 42: 1799\u20131808.","DOI":"10.2337\/diab.42.12.1799"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22 Zanone MM, Catalfamo E, Pietropaolo SL, et al. Glutamic acid decarboxylase and ICA512\/IA-2 autoantibodies as disease markers and relationship to residual beta-cell function and glycemic control in young type 1 diabetic patients. Metabolism 2003; 52: 25\u201359.","DOI":"10.1053\/meta.2003.50003"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23 Delong T, Wiles TA, Baker RL, et al. Pathogenic CD4 T cells in type 1 diabetes recognize epitopes formed by peptide fusion. Science 2016; 351: 711\u2013714.","DOI":"10.1126\/science.aad2791"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24 Babon JA, DeNicola ME, Blodgett DM, et al. Analysis of self-antigen specificity of islet-infiltrating T cells from human donors with type 1 diabetes. Nat Med 2016; 22: 1482\u20131487.","DOI":"10.1038\/nm.4203"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25 Sakai R, Hashimoto Y, Ushigome E, et al. Late-night-dinner is associated with poor glycemic control in people with type 2 diabetes: The KAMOGAWA-DM cohort study. Endocr J 2018; 65: 395\u2013402.","DOI":"10.1507\/endocrj.EJ17-0414"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26 Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 2003; 26 Suppl 1: S5\u201320.","DOI":"10.2337\/diacare.26.2007.S5"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27 The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1997; 20: 1183\u20131197.","DOI":"10.2337\/diacare.20.7.1183"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28 Gao C, Zhang M, Chen L. The comparison of two single-cell sequencing platforms: BD rhapsody and 10x genomics chromium. Curr Genomics 2020; 21: 602\u2013609.","DOI":"10.2174\/1389202921999200625220812"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29 Shannon CE. A mathematical theory of communication. Bell Syst Tech J 1948; 27: 379\u2013423.","DOI":"10.1002\/j.1538-7305.1948.tb01338.x"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30 Grant CE, Bailey TL. XSTREME: comprehensive motif analysis of biological sequence datasets. BioRxiv 2021; 2021.09.02.458722. DOI: 10.1101\/2021.09.02.458722","DOI":"10.1101\/2021.09.02.458722"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31 Huang LP, Lyu SC, Clayberger C, Krensky AM. Granulysin-mediated tumor rejection in transgenic mice. J Immunol 2007; 178: 77\u201384.","DOI":"10.4049\/jimmunol.178.1.77"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32 Walch M, Dotiwala F, Mulik S, et al. Cytotoxic cells kill intracellular bacteria through granulysin-mediated delivery of granzymes. Cell 2014; 157: 1309\u20131323.","DOI":"10.1016\/j.cell.2014.03.062"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33 Uddin J, Gonzalez AE, Gilman RH, et al. Mechanisms regulating monocyte CXCL8 secretion in neurocysticercosis and the effect of antiparasitic therapy. J Immunol 2010; 185: 4478\u20134484.","DOI":"10.4049\/jimmunol.0904158"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34 Sad S, Marcotte R, Mosmann TR. Cytokine-induced differentiation of precursor mouse CD8+ T cells into cytotoxic CD8+ T cells secreting Th1 or Th2 cytokines. Immunity 1995; 2: 271\u2013279.","DOI":"10.1016\/1074-7613(95)90051-9"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35 Kobayashi H, Hosono O, Iwata S, et al. The tetraspanin CD9 is preferentially expressed on the human CD4(+)CD45RA+ naive T cell population and is involved in T cell activation. Clin Exp Immunol 2004; 137: 101\u2013108.","DOI":"10.1111\/j.1365-2249.2004.02494.x"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36 Voynova EN, Skinner J, Bolland S. Expansion of an atypical NK cell subset in mouse models of systemic lupus erythematosus. J Immunol 2015; 194: 1503\u20131513.","DOI":"10.4049\/jimmunol.1402673"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37 Tewary P, Yang D, de la Rosa G, et al. Granulysin activates antigen-presenting cells through TLR4 and acts as an immune alarmin. Blood 2010; 116: 3465\u20133474.","DOI":"10.1182\/blood-2010-03-273953"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38 Kerlan-Candon S, Louis-Plence P, Wiedemann A, et al. Specific overexpression of rheumatoid arthritis-associated HLA-DR alleles and presentation of low-affinity peptides. Arthritis Rheum 2001; 44: 1281\u20131292.","DOI":"10.1002\/1529-0131(200106)44:6<1281::AID-ART220>3.0.CO;2-2"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39 Marca V, Gianchecchi E, Fierabracci A. Type 1 diabetes and its multi-factorial pathogenesis: the putative role of NK cells. Int J Mol Sci 2018; 19: 794.","DOI":"10.3390\/ijms19030794"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40 Khan FU, Khongorzul P, Raki AA, Rajasekaran A, Gris D, Amrani A. Dendritic cells and their immunotherapeutic potential for treating type 1 diabetes. Int J Mol Sci 2022; 9: 4885.","DOI":"10.3390\/ijms23094885"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41 Chatenoud L, Thervet E, Primo J, Bach JF. Anti-CD3 antibody induces long-term remission of overt autoimmunity in nonobese diabetic mice. Proc Natl Acad Sci U S A 1994; 91: 123\u2013127.","DOI":"10.1073\/pnas.91.1.123"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42 Eizirik DL, Colli ML, Ortis F. The role of inflammation in insulitis and beta-cell loss in type 1 diabetes. Nat Rev Endocrinol 2009; 5: 219\u2013226.","DOI":"10.1038\/nrendo.2009.21"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43 Arif S, Tree TI, Astill TP, et al. Autoreactive T cell responses show proinflammatory polarization in diabetes but a regulatory phenotype in health. J Clin Invest 2004; 113: 451\u2013463.","DOI":"10.1172\/JCI200419585"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44 Kuriya G, Uchida T, Akazawa S, et al. Double deficiency in IL-17 and IFN-\u03b3 signalling significantly suppresses the development of diabetes in the NOD mouse. Diabetologia 2013; 56: 1773\u20131780.","DOI":"10.1007\/s00125-013-2935-8"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45 Li CR, Mueller EE, Bradley LM. Islet antigen-specific Th17 cells can induce TNF-\u03b1-dependent autoimmune diabetes. J Immunol 2014; 192: 1425\u20131432.","DOI":"10.4049\/jimmunol.1301742"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46 Salomon B, Lenschow DJ, Rhee L, et al. B7\/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes. Immunity 2000; 12: 431\u2013440.","DOI":"10.1016\/S1074-7613(00)80195-8"},{"key":"47","doi-asserted-by":"crossref","unstructured":"47 Wildin RS, Freitas A. IPEX and FOXP3: clinical and research perspectives. J Autoimmun 2005; 25 Suppl: 56\u201362.","DOI":"10.1016\/j.jaut.2005.04.008"},{"key":"48","doi-asserted-by":"crossref","unstructured":"48 Hu CY, Rodriguez-Pinto D, Du W, et al. Treatment with CD20-specific antibody prevents and reverses autoimmune diabetes in mice. J Clin Invest 2007; 117: 3857\u20133867.","DOI":"10.1172\/JCI32405"},{"key":"49","doi-asserted-by":"crossref","unstructured":"49 Serreze DV, Chapman HD, Varnum DS, et al. B lymphocytes are essential for the initiation of T cell-mediated autoimmune diabetes: analysis of a new \u201cspeed congenic\u201d stock of NOD.Ig mu null mice. J Exp Med 1996; 184: 2049\u20132053.","DOI":"10.1084\/jem.184.5.2049"},{"key":"50","doi-asserted-by":"crossref","unstructured":"50 Xiu Y, Wong CP, Bouaziz J-D, et al. B lymphocyte depletion by CD20 monoclonal antibody prevents diabetes in nonobese diabetic mice despite isotype-specific differences in Fc gamma R effector functions. J Immunol 2008; 180: 2863\u20132875.","DOI":"10.4049\/jimmunol.180.5.2863"},{"key":"51","doi-asserted-by":"crossref","unstructured":"51 Blackburn SD, Shin H, Haining WN, et al. Coregulation of CD8+ T cell exhaustion by multiple inhibitory receptors during chronic viral infection. Nat Immunol 2009; 10: 29\u201337.","DOI":"10.1038\/ni.1679"},{"key":"52","doi-asserted-by":"crossref","unstructured":"52 Yano N, Endoh M, Nomoto Y, Sakai H, Rifai A. Increase of HLA-DR-positive natural killer cells in peripheral blood from patients with IgA nephropathy. Hum Immunol 1996; 49: 64\u201370.","DOI":"10.1016\/0198-8859(96)00057-2"},{"key":"53","doi-asserted-by":"crossref","unstructured":"53 Streltsova MA, Erokhina SA, Kanevskiy LM, et al. Recurrent stimulation of natural killer cell clones with K562 expressing membrane-bound interleukin-21 affects their phenotype, interferon-\u03b3 production, and lifespan. Int J Mol Sci 2019; 20: 443.","DOI":"10.3390\/ijms20020443"},{"key":"54","doi-asserted-by":"crossref","unstructured":"54 Evans JH, Horowitz A, Mehrabi M, et al. A distinct subset of human NK cells expressing HLA-DR expand in response to IL-2 and can aid immune responses to BCG. Eur J Immunol 2011; 41: 1924\u20131933.","DOI":"10.1002\/eji.201041180"},{"key":"55","doi-asserted-by":"crossref","unstructured":"55 Luo Z, Li Z, Martin L, et al. Increased natural killer cell activation in HIV-infected immunologic non-responders correlates with CD4+ T cell recovery after antiretroviral therapy and viral suppression. PLoS One 2017; 12: e0167640.","DOI":"10.1371\/journal.pone.0167640"},{"key":"56","doi-asserted-by":"crossref","unstructured":"56 Kallionp\u00e4\u00e4 H, Somani J, Tuomela S, et al. Early detection of peripheral blood cell signature in children developing \u03b2-cell autoimmunity at a young age. Diabetes 2019; 68: 2024\u20132034.","DOI":"10.2337\/db19-0287"},{"key":"57","doi-asserted-by":"crossref","unstructured":"57 Jhun H, Choi J, Hong J, et al. IL-32\u03b3 overexpression accelerates streptozotocin (STZ)-induced type 1 diabetes. Cytokine 2014; 69: 1\u20135.","DOI":"10.1016\/j.cyto.2014.05.002"},{"key":"58","doi-asserted-by":"crossref","unstructured":"58 Voehringer D, Reese TA, Huang X, Shinkai K, Locksley RM. Type 2 immunity is controlled by IL-4\/IL-13 expression in hematopoietic non-eosinophil cells of the innate immune system. J Exp Med 2006; 203: 1435\u20131446.","DOI":"10.1084\/jem.20052448"},{"key":"59","doi-asserted-by":"crossref","unstructured":"59 Ukah TK, Cattin-Roy AN, Chen W, Miller MM, Barik S, Zaghouani H. On the role IL-4\/IL-13 heteroreceptor plays in regulation of type 1 diabetes. J Immunol 2017; 199: 894\u2013902.","DOI":"10.4049\/jimmunol.1700410"},{"key":"60","doi-asserted-by":"crossref","unstructured":"60 Kakuta Y, Nakano T, Naito T, et al. Repertoire analysis of memory T-cell receptors in Japanese patients with inflammatory bowel disease. JGH Open 2020; 4: 624\u2013631.","DOI":"10.1002\/jgh3.12305"}],"container-title":["Journal of Clinical Biochemistry and Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jcbn\/76\/1\/76_24-86\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,3]],"date-time":"2025-01-03T23:09:09Z","timestamp":1735945749000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jcbn\/76\/1\/76_24-86\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":60,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.3164\/jcbn.24-86","relation":{},"ISSN":["0912-0009","1880-5086"],"issn-type":[{"value":"0912-0009","type":"print"},{"value":"1880-5086","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025]]},"article-number":"24-86"}}